Taylor Hudson
banner
trae1992.bsky.social
Taylor Hudson
@trae1992.bsky.social
Gene Editor
Computational Biologist @innovativegenomics.bsky.social
Berkeley MCB PhD Student
Words can’t express what it meant to work on such a historic case in science and medicine. It was truly a call to action across institutions to save a life. I think I speak for everyone involved when I say our greatest hope is that medical opportunity becomes accessible to all who need it.
In a medical breakthrough, a team including IGI’s
@urnov.bsky.social & @giannikopoulosp.bsky.social created an on-demand #CRISPR therapy for an infant with a deadly gene mutation — developed, approved, and delivered to the patient in just 6 months.

Read more: ow.ly/G0Bg50VTonC

#RareDisease 🧬
May 15, 2025 at 5:40 PM
Reposted by Taylor Hudson
The IGI has partnered with operating companies of the Danaher corporation to build a framework - and a companion cookbook - for CRISPR Cures on-demand.
How are we doing? See below.
www.genengnews.com/topics/genom...
Danaher-IGI Beacon for CRISPR Cures Celebrates One-Year Anniversary
CRISPR leaders came together to celebrate the one-year anniversary of the Danaher-IGI Beacon for CRISPR Cures collaboration, hosted at the IGI in Berkeley.
www.genengnews.com
March 29, 2025 at 5:17 PM
Reposted by Taylor Hudson
the tool of the elite bioinformatician
December 10, 2024 at 5:38 PM
Reposted by Taylor Hudson
UK innovation in public health: vaccination, antisepsis, clinical trials, antibiotics ... and now - CRISPR as a national cures platform for genetic disease! The @innovativegenomics.bsky.social is thrilled to be part of the the MRC Therapeutic Genomics CoRe.
🇺🇸✖️🇬🇧🟰💊‼️
www.ukri.org/news/mrc-lau...
MRC launches two £50m centres for cutting-edge gene therapies
MRC is launching its first two Centres of Research Excellence, which will develop transformative new advanced therapeutics for currently untreatable diseases.
www.ukri.org
December 11, 2024 at 1:18 PM